Mitochondrial diseases

Clinical trial ongoing at the Institute:

  • Mitochondriopathies register: prospective follow-up of a cohort of adult patients with mitochondrial diseases (observational study)
  • REN001-201 / STRIDE: A double-blind, placebo-controlled study to evaluate the efficacy and safety of 24 weeks treatment with REN001 in patients with primary mitochondrialmyopathy (PMM)
  • REN001-202: An open-label, multi-centre study to evaluate the long-term safety and tolerability of REN001 in subjects with primary mitochondrial myopathy (PMM)



Mitochondriopathies register

REN001-201 / STRIDE


Intervention REN001 REN001
Principal investigators
Pascal Laforêt Tanya Stojkovic Tanya Stojkovic
Sponsor Institut de Myologie Reneo Reneo
Study status Ongoing Ongoing Ongoing
Recruitment status Ongoing Completed Ongoing
Population Adult Adult Adult
  + infos on + infos on